跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“Sec61/translocon”
全部
55
临床试验
28
药物
6
机构
1
资讯
20
8个月前
Enodia Therapeutics Secures €20.7M Seed Funding to Advance Novel Protein Degradation Platform Targeting SEC61 Translocon
去年
Enodia Therapeutics Launches with Novel Protein Degradation Platform Targeting Cancer and Inflammatory Diseases
10个月前
Gate Bioscience Raises $65 Million Series B to Advance Novel Oral Molecular Gate Therapies into Clinical Trials
5个月前
Mission BioCapital Opens $4 Million 2026 Platinum Program for Global Biotech Startups
去年
ProteoNic Launches 2G UNic Transposon Platform for Enhanced Biologics Production
2年前
TransCon CNP Demonstrates Superior Growth in Achondroplasia Trial
2年前
TransCon CNP Demonstrates Superior Growth Velocity in Achondroplasia Trial
去年
TransCon hGH Meets Primary Endpoint in Turner Syndrome Trial
去年
TransCon PTH Shows Sustained 4-Year Efficacy in Hypoparathyroidism Patients
去年
Transposon Therapeutics' TPN-101 Shows Promise in Phase 2 ALS/FTD Trial
第 1 页,共 2 页
上一页
下一页